Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Fries, D; Innerhofer, P; Perger, P; Gutl, M; Heil, S; Hofmann, N; Kneifel, W; Neuner, L; Pernerstorfer, T; Pfanner, G; Schochl, H; Ziegler, B; Kolblinger, C; Kozek-Langenecker, S.
Coagulation management in trauma-related massive bleeding. - Recommendations of the Task Force for Coagulation (AGPG) of the Austrian Society of Anesthesiology, Resuscitation and Intensive Care Medicine (OGARI)
Anasthesiol Intensivmed Notfallmed Schmerzther. 2010; 45(9):552-561
Doi: 10.1055/s-0030-1265746
Web of Science
PubMed
FullText
FullText_MUG
- Autor*innen der Med Uni Graz:
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Even nowadays and at specialized centers, one of the leading causes of death is exsanguination. Trauma-induced coagulopathy (TIC) occuring with massive blood loss primarily results from loss of coagualtion factors and platelets and is aggravated by hemodilution. In addition, hyperfibrinolysis, hypothermia, acidosis and hypocalcaemia also contribute to the development of severe haemostatic derangement. During the past few years new insights into the pathophysiology of TIC and the widespread use of viscoelastic coagulation monitoring provoked the development of alternative treatment concepts. As for the previously recommended standard therapy using fresh frozen plasma and platelet concentrates also for alternative strategies no data from large prospective randomized studies are available until now, however, the evidence is growing favoring the use of coagulation factor concentrates guided by viscoelastic measurements.
- Find related publications in this database (using NLM MeSH Indexing)
- Anticoagulants - therapeutic use
- Anticoagulants -
- Hemorrhage - drug therapy
- Humans -
- Intensive Care - standards
- Practice Guidelines as Topic -
- Resuscitation - standards
- Wounds and Injuries - complications